showed that upregulation of ABCB1 and ABCC1 transporters was associated with resistance to ADC-containing pyrrolobenzodiazepine (PBD) and that inhibiting these transporters could restore drug sensitivity in previously resistant cancer cells (67). Here, ABCB1 is linked to cancer.